JNJ Johnson & Johnson

"The fair market value of fixed rate securities may be adversely impacted due to a rise in interest rates, while floating rate securities may produce less income than predicted if interest rates fall."

distress relevance: 0.66 market specificity: 0.41 score: 0.390 mda

anchor: rising interest rates have significantly reduced the fair value of our portfolio

"The Company anticipates that operating cash flows, the ability to raise funds from external sources, borrowing capacity from existing committed credit facilities and access to the commercial paper markets will continue to provide sufficient resources to fund operating needs, including the Company’s reserve balance of approximately $3.4 billion related to talc matters, $2.0 billion related to the c"

distress relevance: 0.52 market specificity: 0.44 score: 0.316 mda

anchor: our cash reserves may be insufficient to fund operations

"The primary sources and uses of cash that contributed to the $4.4 billion decrease were: Q4 2024 Cash and cash equivalents balance cash generated from operating activities net cash used for investing activities net cash used for financing activities effect of exchange rate and rounding Q4 2025 Cash and cash equivalents balance In addition, the Company had $0.4 billion in marketable securities at t"

distress relevance: 0.60 market specificity: 0.29 score: 0.299 mda

anchor: cash and cash equivalents declined significantly

"In addition, the Company monitors the global capital markets on an ongoing basis and from time to time may raise capital when market conditions are favorable."

distress relevance: 0.48 market specificity: 0.44 score: 0.293 mda

anchor: we may need to raise additional capital to fund operations

"The Company has established privacy compliance programs and controls with which our businesses worldwide are required to comply."

distress relevance: 0.56 market specificity: 0.31 score: 0.292 risk_factors

anchor: regulatory consent order restricts our business activities

"The fair market value of fixed rate securities may be adversely impacted due to a rise in interest rates, while floating rate securities may produce less income than predicted if interest rates fall."

distress relevance: 0.66 market specificity: 0.38 score: 0.374 mda

anchor: rising interest rates have significantly reduced the fair value of our portfolio

"This exchange resulted in a loss of approximately $0.4 billion recorded in Other (income) expense."

distress relevance: 0.58 market specificity: 0.37 score: 0.326 mda

anchor: significant unrealized losses that would be realized if we sold securities

"The Company anticipates that operating cash flows, the ability to raise funds from external sources, borrowing capacity from existing committed credit facilities and access to the commercial paper markets will continue to provide sufficient resources to fund operating needs, including the Company's remaining balance to be paid on the agreement to settle opioid litigation for approximately $1.5 bil"

distress relevance: 0.48 market specificity: 0.44 score: 0.296 mda

anchor: our cash reserves may be insufficient to fund operations

"In addition, the Company monitors the global capital markets on an ongoing basis and from time to time may raise capital when market conditions are favorable."

distress relevance: 0.48 market specificity: 0.44 score: 0.293 mda

anchor: we may need to raise additional capital to fund operations

"The Company has established privacy compliance programs and controls with which our businesses worldwide are required to comply."

distress relevance: 0.56 market specificity: 0.30 score: 0.290 risk_factors

anchor: regulatory consent order restricts our business activities

"The fair market value of fixed rate securities may be adversely impacted due to a rise in interest rates, while floating rate securities may produce less income than predicted if interest rates fall."

distress relevance: 0.66 market specificity: 0.38 score: 0.374 mda

anchor: rising interest rates have significantly reduced the fair value of our portfolio

"The lower average cash, cash equivalents and marketable securities was primarily due to the acquisition of Abiomed in late December of 2022."

distress relevance: 0.50 market specificity: 0.46 score: 0.308 mda

anchor: cash and cash equivalents declined significantly

"The Company anticipates that operating cash flows, the ability to raise funds from external sources, borrowing capacity from existing committed credit facilities and access to the commercial paper markets will continue to provide sufficient resources to fund operating needs, including the Company's remaining balance to be paid on the agreement to settle opioid litigation for approximately $2.1 bil"

distress relevance: 0.48 market specificity: 0.46 score: 0.298 mda

anchor: our cash reserves may be insufficient to fund operations

"In addition, the Company monitors the global capital markets on an ongoing basis and from time to time may raise capital when market conditions are favorable."

distress relevance: 0.48 market specificity: 0.44 score: 0.293 mda

anchor: we may need to raise additional capital to fund operations

"A 1% (100 basis points) change in spread on the Company’s interest rate sensitive investments would either increase or decrease the unrealized value of cash equivalents and current marketable securities by less than $0.8 billion."

distress relevance: 0.50 market specificity: 0.40 score: 0.290 mda

anchor: rising interest rates have significantly reduced the fair value of our portfolio